Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

Published on 20 Jan 2025 on Zacks · via Yahoo Finance

The FDA approves Amgen's Lumakras in combination with Vectibix for treating previously treated...

Read the rest of the article

Start tracking your investments with Statfolio

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus ...

Insider Monkey · via Yahoo Finance 20 Jan 2025

The FDA approves Amgen's Lumakras in combination with Vectibix for treating previously treated...

Zacks · via Yahoo Finance 20 Jan 2025

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this articl...

Insider Monkey · via Yahoo Finance 19 Jan 2025

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going ...

Insider Monkey · via Yahoo Finance 19 Jan 2025

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are...

Insider Monkey · via Yahoo Finance 19 Jan 2025

We recently compiled a list of the Louis Navellier’s Top 15 Long-Term Stock Picks. In this articl...

Insider Monkey · via Yahoo Finance 18 Jan 2025

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15...

Benzinga · via Yahoo Finance 17 Jan 2025

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are go...

Insider Monkey · via Yahoo Finance 16 Jan 2025

Sanofi's Sarclisa SC formulation shows non-inferiority versus Sarclisa IV infusion in a late-stag...

Zacks · via Yahoo Finance 14 Jan 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.85%

Investing.com 13 Jan 2025